WHA 2018 Highlights – Dr Tedros On Universal Health Coverage Momentum; Azar Says World “Woefully Underprepared” For Epidemics 25/05/2018 John Zarocostas Below are a few highlights of key developments taking place during this week's World Health Assembly (WHA). The head of the World Health Organization speaks on the nexus of primary health care and universal health coverage, and US Health Secretary Alex Azar told an industry side event that the world is still unprepared to battle another pandemic like the 1918 Spanish flu. Continue reading -> WHO, World Bank Establish New Initiative To Help World Prepare For Emergencies 24/05/2018 Catherine Saez The World Health Organization and the World Bank Group today announced the launch of a new mechanism to strengthen global health security. WHO Director General Tedros Adhanom Ghebreyesus (Dr Tedros) had signalled the creation of this mechanism a few weeks ago in his opening remarks at the opening of the World Health Assembly this week. […] Continue reading -> WHO Director Dr Tedros Opens His First Annual World Health Assembly With ‘Keys For Success’ 21/05/2018 Catherine Saez World Health Organization Director General Tedros Adhanom Ghebreyesus (“Dr Tedros”) in his first speech in his function at head of the World Health Assembly described three keys to reach the ambitious goals of the organisation. He envisioned a transformed WHO helped by a strong leadership team, called for political commitment for which he said most […] Continue reading -> AI Takes Multidimensional Role In Emergency Response And Outbreaks 20/05/2018 Catherine Saez In an age where emphasis on the use of artificial intelligence (AI) for the good of humanity is increasing, last week’s AI for Good Global Summit at the International Telecommunication Union (ITU) brought leading experts together to demonstrate the multidimensionality of AI in emergency response and outbreaks, as well as in risk reduction. Continue reading -> Global Health Funding Flows As WHO, Gavi, Global Fund Benefit 27/03/2018 William New Actions by governments in recent days show funding for global health continues to be a priority for some countries. Geneva-based institutions and their programs around the world are among the beneficiaries. Continue reading -> Do We Need A Global Body To Set Priorities For Diseases And Research? 14/02/2018 William New A recent panel of health experts gathered at the hallowed Swiss Intellectual Property Institute in Bern (which counts Albert Einstein among its alumni) tackled some of the toughest questions facing global health policymakers with an eye toward actually solving them and not just restating polarised positions. One of the ideas discussed at the event was how priorities for diseases and research are handled at the global level. Continue reading -> WIPO Hosts Widely Represented Discussion On Vaccine Innovation And Access 09/11/2017 Catherine Saez A well-represented set of experts this week held discussions on the current situation of access to vaccines, the market, the role of pharmaceutical companies, and partnerships. Vaccines were not a field much affected by patents in the past, but the situation has changed and new vaccines are now covered by intellectual property, which might constitute a barrier to access, according to speakers. Continue reading -> World Health Summit: Failing Business Models In AMR And Vaccination 19/10/2017 Monika Ermert BERLIN -- With antimicrobial resistance (AMR) on the rise worldwide there is no time to lose for developing new antibiotic drugs, experts said during one of the last panels of this year’s World Health Summit in Berlin Tuesday. As in several other rounds during the three-day event, industry representatives underlined that there is an issue with the business model due to high risk and low return of investment for research in this area. Continue reading -> Mechanism To Assess Trade Agreements Needed, UN Forum On Access To Medicines Hears 10/10/2017 Peter Kenny A mechanism to systematically assess trade agreements from a public health perspective, including accession agreements of the World Trade Organization and European Patent Office’s validation agreements is needed, says Ellen ´t Hoen, senior researcher at the Global Health Unit of the University Medical Centre, Groningen, The Netherlands. who publishes the Medicines Law and Policy website. Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO, World Bank Establish New Initiative To Help World Prepare For Emergencies 24/05/2018 Catherine Saez The World Health Organization and the World Bank Group today announced the launch of a new mechanism to strengthen global health security. WHO Director General Tedros Adhanom Ghebreyesus (Dr Tedros) had signalled the creation of this mechanism a few weeks ago in his opening remarks at the opening of the World Health Assembly this week. […] Continue reading -> WHO Director Dr Tedros Opens His First Annual World Health Assembly With ‘Keys For Success’ 21/05/2018 Catherine Saez World Health Organization Director General Tedros Adhanom Ghebreyesus (“Dr Tedros”) in his first speech in his function at head of the World Health Assembly described three keys to reach the ambitious goals of the organisation. He envisioned a transformed WHO helped by a strong leadership team, called for political commitment for which he said most […] Continue reading -> AI Takes Multidimensional Role In Emergency Response And Outbreaks 20/05/2018 Catherine Saez In an age where emphasis on the use of artificial intelligence (AI) for the good of humanity is increasing, last week’s AI for Good Global Summit at the International Telecommunication Union (ITU) brought leading experts together to demonstrate the multidimensionality of AI in emergency response and outbreaks, as well as in risk reduction. Continue reading -> Global Health Funding Flows As WHO, Gavi, Global Fund Benefit 27/03/2018 William New Actions by governments in recent days show funding for global health continues to be a priority for some countries. Geneva-based institutions and their programs around the world are among the beneficiaries. Continue reading -> Do We Need A Global Body To Set Priorities For Diseases And Research? 14/02/2018 William New A recent panel of health experts gathered at the hallowed Swiss Intellectual Property Institute in Bern (which counts Albert Einstein among its alumni) tackled some of the toughest questions facing global health policymakers with an eye toward actually solving them and not just restating polarised positions. One of the ideas discussed at the event was how priorities for diseases and research are handled at the global level. Continue reading -> WIPO Hosts Widely Represented Discussion On Vaccine Innovation And Access 09/11/2017 Catherine Saez A well-represented set of experts this week held discussions on the current situation of access to vaccines, the market, the role of pharmaceutical companies, and partnerships. Vaccines were not a field much affected by patents in the past, but the situation has changed and new vaccines are now covered by intellectual property, which might constitute a barrier to access, according to speakers. Continue reading -> World Health Summit: Failing Business Models In AMR And Vaccination 19/10/2017 Monika Ermert BERLIN -- With antimicrobial resistance (AMR) on the rise worldwide there is no time to lose for developing new antibiotic drugs, experts said during one of the last panels of this year’s World Health Summit in Berlin Tuesday. As in several other rounds during the three-day event, industry representatives underlined that there is an issue with the business model due to high risk and low return of investment for research in this area. Continue reading -> Mechanism To Assess Trade Agreements Needed, UN Forum On Access To Medicines Hears 10/10/2017 Peter Kenny A mechanism to systematically assess trade agreements from a public health perspective, including accession agreements of the World Trade Organization and European Patent Office’s validation agreements is needed, says Ellen ´t Hoen, senior researcher at the Global Health Unit of the University Medical Centre, Groningen, The Netherlands. who publishes the Medicines Law and Policy website. Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Director Dr Tedros Opens His First Annual World Health Assembly With ‘Keys For Success’ 21/05/2018 Catherine Saez World Health Organization Director General Tedros Adhanom Ghebreyesus (“Dr Tedros”) in his first speech in his function at head of the World Health Assembly described three keys to reach the ambitious goals of the organisation. He envisioned a transformed WHO helped by a strong leadership team, called for political commitment for which he said most […] Continue reading -> AI Takes Multidimensional Role In Emergency Response And Outbreaks 20/05/2018 Catherine Saez In an age where emphasis on the use of artificial intelligence (AI) for the good of humanity is increasing, last week’s AI for Good Global Summit at the International Telecommunication Union (ITU) brought leading experts together to demonstrate the multidimensionality of AI in emergency response and outbreaks, as well as in risk reduction. Continue reading -> Global Health Funding Flows As WHO, Gavi, Global Fund Benefit 27/03/2018 William New Actions by governments in recent days show funding for global health continues to be a priority for some countries. Geneva-based institutions and their programs around the world are among the beneficiaries. Continue reading -> Do We Need A Global Body To Set Priorities For Diseases And Research? 14/02/2018 William New A recent panel of health experts gathered at the hallowed Swiss Intellectual Property Institute in Bern (which counts Albert Einstein among its alumni) tackled some of the toughest questions facing global health policymakers with an eye toward actually solving them and not just restating polarised positions. One of the ideas discussed at the event was how priorities for diseases and research are handled at the global level. Continue reading -> WIPO Hosts Widely Represented Discussion On Vaccine Innovation And Access 09/11/2017 Catherine Saez A well-represented set of experts this week held discussions on the current situation of access to vaccines, the market, the role of pharmaceutical companies, and partnerships. Vaccines were not a field much affected by patents in the past, but the situation has changed and new vaccines are now covered by intellectual property, which might constitute a barrier to access, according to speakers. Continue reading -> World Health Summit: Failing Business Models In AMR And Vaccination 19/10/2017 Monika Ermert BERLIN -- With antimicrobial resistance (AMR) on the rise worldwide there is no time to lose for developing new antibiotic drugs, experts said during one of the last panels of this year’s World Health Summit in Berlin Tuesday. As in several other rounds during the three-day event, industry representatives underlined that there is an issue with the business model due to high risk and low return of investment for research in this area. Continue reading -> Mechanism To Assess Trade Agreements Needed, UN Forum On Access To Medicines Hears 10/10/2017 Peter Kenny A mechanism to systematically assess trade agreements from a public health perspective, including accession agreements of the World Trade Organization and European Patent Office’s validation agreements is needed, says Ellen ´t Hoen, senior researcher at the Global Health Unit of the University Medical Centre, Groningen, The Netherlands. who publishes the Medicines Law and Policy website. Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
AI Takes Multidimensional Role In Emergency Response And Outbreaks 20/05/2018 Catherine Saez In an age where emphasis on the use of artificial intelligence (AI) for the good of humanity is increasing, last week’s AI for Good Global Summit at the International Telecommunication Union (ITU) brought leading experts together to demonstrate the multidimensionality of AI in emergency response and outbreaks, as well as in risk reduction. Continue reading -> Global Health Funding Flows As WHO, Gavi, Global Fund Benefit 27/03/2018 William New Actions by governments in recent days show funding for global health continues to be a priority for some countries. Geneva-based institutions and their programs around the world are among the beneficiaries. Continue reading -> Do We Need A Global Body To Set Priorities For Diseases And Research? 14/02/2018 William New A recent panel of health experts gathered at the hallowed Swiss Intellectual Property Institute in Bern (which counts Albert Einstein among its alumni) tackled some of the toughest questions facing global health policymakers with an eye toward actually solving them and not just restating polarised positions. One of the ideas discussed at the event was how priorities for diseases and research are handled at the global level. Continue reading -> WIPO Hosts Widely Represented Discussion On Vaccine Innovation And Access 09/11/2017 Catherine Saez A well-represented set of experts this week held discussions on the current situation of access to vaccines, the market, the role of pharmaceutical companies, and partnerships. Vaccines were not a field much affected by patents in the past, but the situation has changed and new vaccines are now covered by intellectual property, which might constitute a barrier to access, according to speakers. Continue reading -> World Health Summit: Failing Business Models In AMR And Vaccination 19/10/2017 Monika Ermert BERLIN -- With antimicrobial resistance (AMR) on the rise worldwide there is no time to lose for developing new antibiotic drugs, experts said during one of the last panels of this year’s World Health Summit in Berlin Tuesday. As in several other rounds during the three-day event, industry representatives underlined that there is an issue with the business model due to high risk and low return of investment for research in this area. Continue reading -> Mechanism To Assess Trade Agreements Needed, UN Forum On Access To Medicines Hears 10/10/2017 Peter Kenny A mechanism to systematically assess trade agreements from a public health perspective, including accession agreements of the World Trade Organization and European Patent Office’s validation agreements is needed, says Ellen ´t Hoen, senior researcher at the Global Health Unit of the University Medical Centre, Groningen, The Netherlands. who publishes the Medicines Law and Policy website. Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Global Health Funding Flows As WHO, Gavi, Global Fund Benefit 27/03/2018 William New Actions by governments in recent days show funding for global health continues to be a priority for some countries. Geneva-based institutions and their programs around the world are among the beneficiaries. Continue reading -> Do We Need A Global Body To Set Priorities For Diseases And Research? 14/02/2018 William New A recent panel of health experts gathered at the hallowed Swiss Intellectual Property Institute in Bern (which counts Albert Einstein among its alumni) tackled some of the toughest questions facing global health policymakers with an eye toward actually solving them and not just restating polarised positions. One of the ideas discussed at the event was how priorities for diseases and research are handled at the global level. Continue reading -> WIPO Hosts Widely Represented Discussion On Vaccine Innovation And Access 09/11/2017 Catherine Saez A well-represented set of experts this week held discussions on the current situation of access to vaccines, the market, the role of pharmaceutical companies, and partnerships. Vaccines were not a field much affected by patents in the past, but the situation has changed and new vaccines are now covered by intellectual property, which might constitute a barrier to access, according to speakers. Continue reading -> World Health Summit: Failing Business Models In AMR And Vaccination 19/10/2017 Monika Ermert BERLIN -- With antimicrobial resistance (AMR) on the rise worldwide there is no time to lose for developing new antibiotic drugs, experts said during one of the last panels of this year’s World Health Summit in Berlin Tuesday. As in several other rounds during the three-day event, industry representatives underlined that there is an issue with the business model due to high risk and low return of investment for research in this area. Continue reading -> Mechanism To Assess Trade Agreements Needed, UN Forum On Access To Medicines Hears 10/10/2017 Peter Kenny A mechanism to systematically assess trade agreements from a public health perspective, including accession agreements of the World Trade Organization and European Patent Office’s validation agreements is needed, says Ellen ´t Hoen, senior researcher at the Global Health Unit of the University Medical Centre, Groningen, The Netherlands. who publishes the Medicines Law and Policy website. Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Do We Need A Global Body To Set Priorities For Diseases And Research? 14/02/2018 William New A recent panel of health experts gathered at the hallowed Swiss Intellectual Property Institute in Bern (which counts Albert Einstein among its alumni) tackled some of the toughest questions facing global health policymakers with an eye toward actually solving them and not just restating polarised positions. One of the ideas discussed at the event was how priorities for diseases and research are handled at the global level. Continue reading -> WIPO Hosts Widely Represented Discussion On Vaccine Innovation And Access 09/11/2017 Catherine Saez A well-represented set of experts this week held discussions on the current situation of access to vaccines, the market, the role of pharmaceutical companies, and partnerships. Vaccines were not a field much affected by patents in the past, but the situation has changed and new vaccines are now covered by intellectual property, which might constitute a barrier to access, according to speakers. Continue reading -> World Health Summit: Failing Business Models In AMR And Vaccination 19/10/2017 Monika Ermert BERLIN -- With antimicrobial resistance (AMR) on the rise worldwide there is no time to lose for developing new antibiotic drugs, experts said during one of the last panels of this year’s World Health Summit in Berlin Tuesday. As in several other rounds during the three-day event, industry representatives underlined that there is an issue with the business model due to high risk and low return of investment for research in this area. Continue reading -> Mechanism To Assess Trade Agreements Needed, UN Forum On Access To Medicines Hears 10/10/2017 Peter Kenny A mechanism to systematically assess trade agreements from a public health perspective, including accession agreements of the World Trade Organization and European Patent Office’s validation agreements is needed, says Ellen ´t Hoen, senior researcher at the Global Health Unit of the University Medical Centre, Groningen, The Netherlands. who publishes the Medicines Law and Policy website. Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WIPO Hosts Widely Represented Discussion On Vaccine Innovation And Access 09/11/2017 Catherine Saez A well-represented set of experts this week held discussions on the current situation of access to vaccines, the market, the role of pharmaceutical companies, and partnerships. Vaccines were not a field much affected by patents in the past, but the situation has changed and new vaccines are now covered by intellectual property, which might constitute a barrier to access, according to speakers. Continue reading -> World Health Summit: Failing Business Models In AMR And Vaccination 19/10/2017 Monika Ermert BERLIN -- With antimicrobial resistance (AMR) on the rise worldwide there is no time to lose for developing new antibiotic drugs, experts said during one of the last panels of this year’s World Health Summit in Berlin Tuesday. As in several other rounds during the three-day event, industry representatives underlined that there is an issue with the business model due to high risk and low return of investment for research in this area. Continue reading -> Mechanism To Assess Trade Agreements Needed, UN Forum On Access To Medicines Hears 10/10/2017 Peter Kenny A mechanism to systematically assess trade agreements from a public health perspective, including accession agreements of the World Trade Organization and European Patent Office’s validation agreements is needed, says Ellen ´t Hoen, senior researcher at the Global Health Unit of the University Medical Centre, Groningen, The Netherlands. who publishes the Medicines Law and Policy website. Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
World Health Summit: Failing Business Models In AMR And Vaccination 19/10/2017 Monika Ermert BERLIN -- With antimicrobial resistance (AMR) on the rise worldwide there is no time to lose for developing new antibiotic drugs, experts said during one of the last panels of this year’s World Health Summit in Berlin Tuesday. As in several other rounds during the three-day event, industry representatives underlined that there is an issue with the business model due to high risk and low return of investment for research in this area. Continue reading -> Mechanism To Assess Trade Agreements Needed, UN Forum On Access To Medicines Hears 10/10/2017 Peter Kenny A mechanism to systematically assess trade agreements from a public health perspective, including accession agreements of the World Trade Organization and European Patent Office’s validation agreements is needed, says Ellen ´t Hoen, senior researcher at the Global Health Unit of the University Medical Centre, Groningen, The Netherlands. who publishes the Medicines Law and Policy website. Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Mechanism To Assess Trade Agreements Needed, UN Forum On Access To Medicines Hears 10/10/2017 Peter Kenny A mechanism to systematically assess trade agreements from a public health perspective, including accession agreements of the World Trade Organization and European Patent Office’s validation agreements is needed, says Ellen ´t Hoen, senior researcher at the Global Health Unit of the University Medical Centre, Groningen, The Netherlands. who publishes the Medicines Law and Policy website. Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy